Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Formiminoglutamic aciduria, in its moderate form and in the absence of histidine administration, is characterized by mild developmental delay and elevated concentrations of formiminoglutamate (FIGLU) in the urine. A more severe phenotype has been described in five members of a Japanese family and included severe intellectual deficit, psychomotor retardation and megaloblastic anemia.
Features include: Aminoaciduria, Megaloblastic anemia, Elevated urinary formiminoglutamic acid level, and Growth delay and 3 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 2 | Megaloblastic anemia, Hypersegmentation of neutrophil nuclei |
FTCD encodes formimidoyltransferase cyclodeaminase (541 aa). Folate-dependent enzyme, that displays both transferase and deaminase activity. Serves to channel one-carbon units from formiminoglutamate to the folate pool
Formiminoglutamic aciduria is associated with mutations in the FTCD gene on chromosome 21.
The FTCD protein participates in N-formiminoglutamate + tetrahydrofolate = glutamate + 5-formiminotetrahydrofolate pathway.
FTCD is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for FTCD is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for formiminoglutamic aciduria.
2 publications have been identified in PubMed for formiminoglutamic aciduria. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Baheer Abdulwahhab S (2026). [PMID: 41868448](https://pubmed.ncbi.nlm.nih.gov/41868448/). *Cureus*. [Case Report / Case Series]
Huang XW (2026). [PMID: 41452423](https://pubmed.ncbi.nlm.nih.gov/41452423/). *World J Pediatr*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 6:44 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Elevated urinary formiminoglutamic acid level |
Growth and development | 1 | Growth delay |
Brain and nerves | 1 | Intellectual disability |